A phase II, window study of SP1049C as first-line therapy in inoperable metastatic adenocarcinoma of the oesophagus

Citation

• Valle, J. W., Lawrance, J., Brewer, J., Clayton, A., Corrie, P., Alakhov, V., & Ranson, M. (2004). A phase II, window study of SP1049C as first-line therapy in inoperable metastatic adenocarcinoma of the oesophagus. Journal of Clinical Oncology, 22(14_suppl), 4195. doi:10.1200/jco.2004.22.90140.4195

Digital Object Identifier (doi)

• 10.1200/jco.2004.22.90140.4195

Web Of Science Accession Number

Start Page

• 4195

End Page

• 4195

Volume

• 22

Issue

• 14_suppl

Abstract

UOW Authors

•   Ranson, Marie (external author)

Publication Date

• 2004

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Valle, J. W., Lawrance, J., Brewer, J., Clayton, A., Corrie, P., Alakhov, V., & Ranson, M. (2004). A phase II, window study of SP1049C as first-line therapy in inoperable metastatic adenocarcinoma of the oesophagus. Journal of Clinical Oncology, 22(14_suppl), 4195. doi:10.1200/jco.2004.22.90140.4195

Digital Object Identifier (doi)

• 10.1200/jco.2004.22.90140.4195

Web Of Science Accession Number

Start Page

• 4195

End Page

• 4195

Volume

• 22

Issue

• 14_suppl